Analysis of Polar Compounds Using 100% Aqueous Mobile Phases with Agilent ZORBAX Eclipse Plus Phenyl-Hexyl and Other ZORBAX Phenyl Columns

Importance of the Topic

Polar analytes such as organic acids and catecholamine bases pose significant challenges in reversed-phase HPLC due to their low retention in high-aqueous mobile phases and potential phase collapse of conventional C8/C18 columns. Reliable, reproducible separation of these compounds is critical in pharmaceuticals, clinical diagnostics and food analysis for quality control, bioanalytical profiling and flavor or preservative assessment.

Objectives and Study Overview

This application note demonstrates the use of Agilent ZORBAX phenyl-based columns (Eclipse Plus Phenyl-Hexyl, Eclipse XDB-Phenyl, StableBond SB-Phenyl) operated under 100 % aqueous mobile phases for effective separation of

• Aliphatic acids (tartaric, malic, lactic, acetic, citric, propionic)
• Catecholamines (norepinephrine, epinephrine, dopamine, levodopa, tyrosine)

It compares column selectivity, mobile phase additives and examines column stability under dewetting-stress conditions.

Methodology and Instrumentation

HPLC system configuration:

• Agilent 1200 Series Rapid Resolution LC
• G1312B binary pump SL in isocratic mode (water with additives), 1.0 mL/min
• G1376C automatic liquid sampler SL, 5 µL injection
• G1316B thermally controlled column compartment at 25 °C
• G1315-60024 diode array detector monitoring 220, 265, 360 nm

Columns tested:

• Eclipse Plus Phenyl-Hexyl, 4.6×100 mm & 4.6×150 mm, 3.5 µm (p/n 959996-912 & 959961-912)
• Eclipse XDB-Phenyl, 4.6×100 mm & 4.6×150 mm, 3.5 µm (custom & p/n 963967-912)
• StableBond SB-Phenyl, 4.6×100 mm & 4.6×150 mm, 3.5 µm (custom & p/n 863953-912)

Chemicals:

• Milli-Q water (18 MΩ), formic acid, TFA, acetic acid (Sigma-Aldrich)
• Catecholamines and aliphatic acids prepared at 0.2 mg/mL in water

Key Results and Discussion

1. Selectivity Comparison

• Eclipse Plus Phenyl-Hexyl and Eclipse XDB-Phenyl showed nearly identical elution of catecholamines under 0.1 % TFA, with minor tyrosine shifts.
• StableBond SB-Phenyl exhibited alternative peak order reflecting exposed silanol interactions and slightly lower retention.

2. Mobile Phase Additive Effects

• TFA concentration enhanced retention of bases more than formic or acetic acid, consistent with neutralization and ion-pairing effects.
• Sodium phosphate buffers at pH 2.5–3.0 increased retention moderately but were less effective than TFA mobile phases.

3. Separation of Aliphatic Acids

• Under 25 mM phosphate pH 2.5, Eclipse XDB-Phenyl delivered baseline resolution of six acid analytes with no overlaps.
• Eclipse Plus Phenyl-Hexyl showed stronger retention but slight coelution of malic and its impurity.

4. Column Stability under Dewetting Stress

• Eclipse Plus Phenyl-Hexyl maintained retention times and peak shapes through four 30-minute stop-flow cycles, demonstrating resistance to phase collapse.

Benefits and Practical Applications

• Elimination of organic solvent in mobile phase simplifies sample preparation and reduces cost and environmental impact.
• Robust separation of polar acids and bases without ion-pair reagents or HILIC columns enhances MS compatibility.
• Phenyl column choices allow tuning of selectivity via ligand length and endcapping for diverse analyte classes.

Future Trends and Potential Applications

• Integration with mass spectrometry for high-throughput bio-analysis of neurotransmitters and metabolites.
• Extension to other polar analyte classes including small peptides, nucleotides and water-soluble vitamins.
• Development of sub-2 µm phenyl-hexyl phases for ultra-high-pressure applications.

Conclusion

Agilent ZORBAX phenyl-based columns offer reliable high-aqueous separations of polar acids and bases without phase collapse. Choice of ligand (phenyl-hexyl vs ethyl-phenyl) and mobile phase additive (TFA vs buffer) enables optimization of selectivity and retention, supporting routine pharmaceutical, clinical and food analysis workflows.

References

1. L. R. Snyder et al., Practical HPLC Method Development, 2nd Ed., Wiley, 1997.
2. B. A. Bidlingmeyer and A. D. Broske, J. Chrom. Sci., 42, 2004.
3. Lab Med, 30, 512–516, clinical utility of catecholamines, date unknown.
4. Bartek Corp., Self-Teaching Guide for Food Acidulants.
5. W. Long and J. Henderson, Agilent Tech. pub. 5989-7731EN, 2008.
6. U. D. Neue et al., J. Chrom. A, 1063, 2005.
7. Handbook of Pharmaceutical Biotechnology, Wiley, 2007.
8. Analytica Chimica Acta, 399, 249–258, 1999.